NeuraMedica Inc.

OREGON CITY, OR · Founded 2014 · Medtech · Private

Bioabsorbable surgical clip and applier for dura mater closure in spine surgery

Claim this profile

Follows are private to you and power your alerts

Updated · neuramedica.com

Sector
Medtech
Headquarters
OREGON CITY, OR
Founded
2014
Latest Form D
$50K, Jul 2023
Total capital
$4.4M
Federal grants
$3.2M
4 awards · 2016–2019
4.0× sector median 1 award
Private capital raised
$1.2M
3 Form D · last Jul 2023
40 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
1 pending · first 2023

Capital timeline

20162017201820192020202120222023FEDERAL ↑EQUITY ↓Cumulative $4.4M$225K$870K$1.5M$628K1st Form D$40K2nd Form D$1.1M3rd Form D$50K
2016201820202022FEDERAL ↑EQUITY ↓Cumulative $4.4M$225K$870K$1.5M$628K1st Form D$40K2nd Form D$1.1M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$50K
  • Private capital raisedForm D · SEC · 2nd filing$1.1M
  • Federal grantHealth and Human S · Phase II · Development of a novel bioabsorbable clip and applier for rapid closure of the dura mater in open and minimally invasive spine surgery.$628K
  • Private capital raisedForm D · SEC · 1st filing$40K
  • Federal grantHealth and Human S · Phase II · Development of a novel bioabsorbable clip and applier for rapid closure of the dura mater in open and minimally invasive spine surgery.$1.5M
  • Federal grantHealth and Human S · Phase II · Development of a novel bioabsorbable clip and applier for rapid closure of the dura mater in open and minimally invasive spine surgery.$870K
  • Federal grantNSF · Phase I · SBIR Phase I: Development of a novel bioabsorbable clip and applicator for rapid closure of the dura mater during open and minimally invasive spine surgery$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

18months

from NeuraMedica Inc.’s first federal award to its first private round.

First federal award · Dec 2016
NSF · $225K
First Form D · Jun 2018
$40K · 1st Form D
Awards before first raise
3 awards

An association in public records, not a cause or a prediction.

Standing in Medtech · 4531 companies

Line = median
  • Federal contractsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Rachel DreilingerResearcherExecutive Officer, Director, PromoterLinked by 1 patent · $3.2M in grants as PI
  • Coni RosatiDirector, PromoterNamed in SEC Form D filings
  • John AllemanDirectorNamed in SEC Form D filings
  • Michael TippieExecutive Officer, PromoterNamed in SEC Form D filings
  • Neil RoundyExecutive Officer, Director, PromoterNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 2
  • Synchro Motion LLCSimilar federal contract value in Medtech · null in contracts
  • RHAEOS, INCSimilar federal contract value in Medtech · null in contracts
  • Lucira Health, Inc.Similar federal contract value in Medtech · null in contracts
  • BRITESEED, LLCSimilar federal contract value in Medtech · null in contracts
  • KILELE HEALTH INC.Similar federal contract value in Medtech · null in contracts
  • HEALING INNOVATIONS INCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .